Reported Reactions

Devices › Stent, superficial femoral artery, drug-eluting

Device brand name · Stent superficial femoral artery drug-eluting

ELUVIATM Drug-Eluting Vascular Stent System: medical device reports filed with FDA

228 reports name it, 2016–2026. Manufacturer given most often on reports: Boston Scientific. Product code NIU.

228
device reports naming the brand
0% of all MAUDE reports · about 22 a year
32
reports, 12 months to August 2026
11 in the 12 months before
13.6%
classified as malfunction
29.4% across the product code
1.8%
classified as death, as reported
4 reports · not verified by FDA

FDA's MAUDE database holds 228 reports that name the brand "ELUVIATM Drug-Eluting Vascular Stent System" (stent superficial femoral artery drug-eluting), received between April 2016 and August 2026; the manufacturer given most often on reports is Boston Scientific. Spellings of one product vary from report to report.

32 reports arrived in the 12 months to August 2026, up 191% from 11 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (84.6%), malfunction (13.6%) and death (1.8%); across all stent, superficial femoral artery, drug-eluting reports (product code NIU) death is recorded in 0.6% and malfunction in 29.4%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are fracture (11%), material deformation (4.8%) and activation failure (1.3%). The patient problems coded most often are reocclusion, restenosis and obstruction/occlusion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0611Sep 2021: 4Oct 2021: 5Nov 2021: 1Dec 2021: 52022Jan 2022: 2Feb 2022: 1Mar 2022: 3Apr 2022: 2May 2022: 2Jun 2022: 1Jul 2022: 1Aug 2022: 3Sep 2022: 1Oct 2022: 1Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 2Jun 2023: 0Jul 2023: 0Aug 2023: 1Sep 2023: 1Oct 2023: 1Nov 2023: 0Dec 2023: 12024Jan 2024: 1Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 2Jun 2024: 0Jul 2024: 1Aug 2024: 6Sep 2024: 1Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 1Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 3Jun 2025: 1Jul 2025: 5Aug 2025: 0Sep 2025: 3Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 3Feb 2026: 11Mar 2026: 4Apr 2026: 0May 2026: 1Jun 2026: 3Jul 2026: 2Aug 2026: 5

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

026512016: 420162017: 72018: 4220182019: 512020: 2220202021: 262022: 1720222023: 62024: 1120242025: 132026: 292026

Event type and report source

Event type, as classified on the report

Death1.8%4
Injury84.6%193
Malfunction13.6%31
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%228
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 2,857 reports carrying product code NIU. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Fracturea broken bone2511%11%
Material deformation114.8%8.4%
Activation failure31.3%3%
Activation, positioning or separation problem31.3%16.2%
Migrationthe device moved from where it was placed31.3%0.4%
Deformation due to compressive stress10.4%1.5%
Device-device incompatibility10.4%0.4%
Difficult or delayed activation10.4%0.5%
Difficult to advance10.4%0.8%
Entrapment of device10.4%3.5%
Obstruction of flow10.4%1.8%
Occlusion within devicethe device blocked10.4%16.9%
Premature activation10.4%2.5%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Reocclusion8035.1%
Restenosis2912.7%
Obstruction/occlusion2611.4%
Painpain, site not specified2611.4%
Thrombosis2511%
Thrombosis/thrombus167%
Claudication146.1%
Aneurysm83.5%
Arteriosclerosis/ atherosclerosis83.5%
Ischemia62.6%
Occlusion62.6%
Inflammationinflammation31.3%
Pseudoaneurysm31.3%
Swelling/ edema31.3%
Vascular dissection31.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureELUVIATM Drug-Eluting Vascular Stent SystemProduct code NIUAll MAUDE reports
Reports2282,85726,136,888
Share of that pool—8%0%
Classified as death, per 1,000 reports1869
Classified as injury84.6%70%36.2%
Classified as malfunction13.6%29.4%62.3%
Filed by the manufacturer100%96.9%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code NIU

BrandReportsLatest 12 monthsClassified as death
ELUVIA Drug-Eluting Vascular Stent System1,079500.6%
Zilver Ptx Drug-Eluting Peripheral Stent72790%
Zilver Ptx 35 Drug-Eluting Stent590160.7%
Cypher Sirolimus-Eluting Coronary Stent15,051010.3%
Evolution Biliary Controlled-Release Stent - Uncovered194200%
Promus PREMIER6,1591116.3%
Zenith Fenestrated Graft163020.2%
Zilver 635 Biliary Self Expanding Metal Stent362130%
Zilver Flex 35 Vascular Self-Expanding Stent203230.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about ELUVIATM Drug-Eluting Vascular Stent System reports

How many FDA reports name ELUVIATM Drug-Eluting Vascular Stent System?

228 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 32 in the latest 12 months.

What kinds of events are reported?

injury (84.6%), malfunction (13.6%) and death (1.8%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

fracture (11%), material deformation (4.8%), activation failure (1.3%), activation, positioning or separation problem (1.3%) and migration (1.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that ELUVIATM Drug-Eluting Vascular Stent System was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.